B6N.Cg-Tg(DUX4*)1Maar/J

Stock number: 027991
Product name: D4Z4-2.5
Research areas: Neurobiology Research

Description

D4Z4-2.5 transgenic mice recapitulate important epigenetic and DUX4 expression attributes seen in human FSHD1. D4Z4-2.5 mice, along with the control strain (D4Z4-12.5 transgenic mice carrying a normal sized, non-pathogenic allele; Stock No. 028012), may be useful in studying facioscapulohumeral dystrophy.

Detailed description

Facioscapulohumeral dystrophy (FSHD) is an autosomal dominant muscular dystrophy predominantly affecting facial and upper extremity muscles. Hearing loss and retinopathy are frequently observed extramuscular features. FSHD1 is caused by contraction of the D4Z4 macrosatellite repeat to 10 or less D4Z4 units in the subtelomeric region of 4q on the 4A161 haplotype. DUX4 is more efficiently silenced with increasing D4Z4 copy number: human FSHD1 is associated with 1-10 D4Z4 repeat units, whereas the unaffected population has 11-100 D4Z4 repeat units. When expressed in skeletal muscle, the DUX4 transcription factor activates genes normally expressed in the germline (essentially inducing a stem cell program in the postmitotic muscle cell) and also suppresses several genes involved in the innate immune response.

The D4Z4-2.5 transgene contains a FSHD1-sized D4Z4 repeat derived from a human FSHD1 individual (haplotype 4A161; containing 2.5 D4Z4 repeat units followed by the pLAM DUX4 exon 3 with polyA signal). Hemizygous D4Z4-2.5 transgenic mice recapitulate important epigenetic and DUX4 expression attributes seen in human FSHD1; including high DUX4 expression levels in the germline, incomplete epigenetic repression of DUX4 in somatic tissue, and FSHD-specific variegated DUX4 expression in sporadic muscle nuclei associated with D4Z4 chromatin relaxation.

The phenotype listed below compares the D4Z4-2.5 transgenic mice carrying a D4Z4 genomic region from a contracted pathogenic FSHD1 allele (Stock No. 027991) with the D4Z4-12.5 transgenic mice carrying a normal sized, non-pathogenic allele (Stock No. 028012). Unless noted otherwise, hemizygous mice are described.


The fewer (2.5) D4Z4 repeat units in D4Z4-2.5 mice causes inefficient DUX4 repression in somatic tissue (bodywide hypomethylation of D4Z4) and manifests in features of human FSHD1. In contrast, D4Z4-12.5 mice have a D4Z4 repeat array (12.5) that maintains somatic tissue epigenetic silencing of DUX4 at a low enough level sufficient to preclude FSHD1 phenotype in humans.
D4Z4-2.5 mice have abundant levels of DUX4 mRNA in germ line tissues (most notably in testis), in ES cells and in early developmental stages. In D4Z4-12.5 mice, the pattern is similar but at lower levels.
In adult somatic tissue from D4Z4-2.5 mice, DUX4 mRNA expression is low and variegated in all analyzed skeletal muscles, and a variegated expression pattern of DUX4 protein in skeletal muscle nuclei is observed. In adult somatic tissue from D4Z4-12.5 mice, DUX4 transcripts are reproducibly detected only in the tibialis anterior and pectoralis muscles, whereas all other somatic tissues do not show reproducible DUX4 expression.
D4Z4-2.5 mice exhibit chromatin relaxation of the D4Z4 repeats compared to D4Z4-12.5 mice.
In both D4Z4-2.5 and D4Z4-12.5 mice, the overall morphology/histology of the limb and some head muscles appear normal. Hemizygous mice are viable and fertile. The donating investigator also reports that homozygous mice are viable and fertile, and that the number of D4Z4 repeats within each line stays the same through several generations of breeding (i.e., the D4Z4 repeat unit is stable).
Approximately half of the D4Z4-2.5 mice develop eye abnormalities (keratitis) around 8-12 weeks of age.

Development

The D4Z4-2.5 transgene was designed by Dr. Silvere M. van der Maarel (Leiden University Medical Center, The Netherlands) with the human facioscapulohumeral dystrophy (FSHD)-permissive FSHD1 allele. Specifically, an EcoRI fragment derived from the lambda-42 clone of an FSHD1 allele (haplotype 4A161) was obtained. This allele contains two-and-a-half copies of the D4Z4 macrosatellite repeat units (each unit has exons 1-2 of the DUX4 retrogene; with exon 1 encoding a double homeobox transcription factor), the region telomeric to the last repeat (called pLAM) contains DUX4 exon 3 (harboring a polyA signal in haplotype 4A161) and lacks the more downstream DUX4 exons 4-7. This ~13.5 kbp transgene was microinjected into the pronuclei of fertilized oocytes of B6CBAF1/J mice (Charles River Laboratories), and then founder animals were bred to C57BL/6NCrl mice for germline transmission. A single founder line was generated, and found to have 4-6 copies of the transgene integrated onto chromosome 17. The D4Z4-2.5 transgenic colony was then bred with C57BL/6Jico (C57BL/6NCrl) wildtype mice for at least 20 generations prior to sending black male mice to The Jackson Laboratory Repository in 2015. Upon arrival, males were used to cryopreserve sperm. To establish the living D4Z4-2.5 mouse colony, an aliquot of the frozen sperm was used to fertilize oocytes from C57BL/6NJ inbred females (Stock No. 005304).

Allele

Symbol: Tg(DUX4*)1Maar
Name: transgene insertion 1, Silvere van der Maarel
MGI accession ID: MGI:5555034
Generation method: Transgenic
Attributes: Inserted expressed sequence; Humanized sequence
Marker symbol: Tg(DUX4*)1Maar
Marker name: transgene insertion 1, Silvere van der Maarel
Chromosome: 17
Strain of origin: (C57BL/6J x CBA/J)F1
Expressed genes: DUX4,double homeobox 4,human
Site of expression: Reproducible levels of DUX4 mRNA were detected in all analyzed skeletal muscles of adult mice, including affected muscles of the limbs, trunk and head.
Molecular note: This transgene carries a 13.5 kb EcoRI fragment derived from a lambda-42 phage clone encompassing the partially deleted D4Z4 locus of a patient with facioscapulohumeral dystrophy. This allele contains the DUX4 pA signal, but lacks the more downstream exons 6 and 7 and contains 2.5 copies of the D4Z4 unit and flanking sequences. 4 copies of the fragment were integrated on chromosome 17. DUX4 mRNA was detected in germline tissues and variable expression is seen in analyzed somatic tissues including skeletal muscle and in the cerebellum.